Azlocillin pharmacokinetics in patients with cystic fibrosis.
The pharmacokinetics of azlocillin were studied in 10 cystic fibrosis patients, ranging in age from 11 to 28 years. The patients received a 9- to 23-day course of 350 mg of azlocillin per kg in four or six divided daily doses in combination with am aminoglycoside. Blood and urine samples were collec...
Shranjeno v:
| izdano v: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1984
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185602/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6732230/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.25.5.630 |
| Oznake: |
Brez oznak, prvi označite!
|